A relapse prevention study for anxiety patients who want to discontinue antidepressant medication.
Suspended
- Conditions
- Remitted anxiety disorder patients: panic disorder with of without agoraphobia, social phobia and generalized anxiety disorder
- Registration Number
- NL-OMON21398
- Lead Sponsor
- GGZ InGeest (partner van VUMC)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
Included are adults aged 18-65 years, who:
1. Use antidepressants for panic disorder (with or without agoraphobia), social phobia or generalized anxiety disorder;
Exclusion Criteria
Patients with comorbid dementia, psychotic disorder, alcohol or drug dependence or who do not speak Dutch are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is relapse within a year.
- Secondary Outcome Measures
Name Time Method 1. Time to relapse;<br /><br>2. One-year course of anxiety symptoms;<br /> <br>3. Quality of life;<br /><br>4. Patient satisfaction;<br /><br>5. Predictors of relapse;<br /><br>6. Cost-effectivity;<br /><br>7. Cost-utility.